SCHEMBL14968232

SCHEMBL14968232

O=CC(c1c(F)cc(O)cc1F)N1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14968332 0.80 MIF (0.33)
SCHEMBL12987680 0.74 SHBG (0.40)
SCHEMBL14968308 0.67 ESR1 (0.45)
SCHEMBL12987863 0.67 CYP2D6 (0.38)
SCHEMBL14967961 0.64 MAOB (0.40)
SCHEMBL14967871 0.62 TAAR1 (0.35)
Hydrochloric Acid SCHEMBL7459908 0.61 LMNA (0.49)
SCHEMBL12333499 0.60 CA12 (0.41)
SCHEMBL15272244 0.59 CPN1 (0.36)
SCHEMBL14969283 0.59 KMT2A (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2780337-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS Merck Sharp & Dohme Corp. (US) 2014-09-24 EP disclosed
WO-2013074388-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS MERCK SHARP & DOHME CORP. (US) 2013-05-23 WO disclosed